瘢痕(Scar):治療薬開発パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Scar - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Scar Overview 9
Therapeutics Development 10
Pipeline Products for Scar – Overview 10
Pipeline Products for Scar – Comparative Analysis 11
Scar – Therapeutics under Development by Companies 12
Scar – Therapeutics under Investigation by Universities/Institutes 14
Scar – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Scar – Products under Development by Companies 18
Scar – Products under Investigation by Universities/Institutes 20
Scar – Companies Involved in Therapeutics Development 21
3M Drug Delivery Systems 21
AlbireoPharma 22
Altacor Ltd. 23
Amakem NV 24
Beech Tree Labs, Inc. 25
Biomolecular Therapeutics GmbH 26
BiOrion Technologies B.V. 27
Clanotech AB 28
Critical Outcome Technologies Inc. 29
Derma Sciences, Inc. 30
Easton Pharmaceuticals Inc. 31
Escape Therapeutics, Inc. 32
EyeGene, Inc. 33
Fibrocell Science, Inc. 34
FirstString Research, Inc. 35
Juventas Therapeutics, Inc. 36
Kasiak Research Pvt. Ltd. 37
Pergamum AB 38
RXi Pharmaceuticals Corporation 39
Symic Biomedical, Inc. 40
Scar – Therapeutics Assessment 41
Assessment by Monotherapy Products 41
Assessment by Target 42
Assessment by Mechanism of Action 44
Assessment by Route of Administration 46
Assessment by Molecule Type 48
Drug Profiles 50
A-3914 – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
A-5425 – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
AMA-0526 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
azficel-T – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
BMT-101 – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
BOT-191 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
BTL-slo – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
CLT-28643 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CM-101 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
decorin – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
Drug to Agonize Beta 2 Receptor for Wound Scars – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
DSC-127 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
EGS-001 – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
EP-003 – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
FibroStem – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
Granexin – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
ICX-RHY – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
JVS-100 – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
nefopam hydrochloride – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
PXL-01 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
Refaglo – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
RXI-109 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
S-34240 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
Small Molecules for Wounds and Scars – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
Small Molecules to Activate SOX-9 for Scar – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
Synthetic Peptides to Antagonize TGF-Beta Receptor for Diabetic Foot Ulcers, Pulmonary Fibrosis and Dermatology – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
tranilast – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
Scar – Recent Pipeline Updates 82
Scar – Dormant Projects 94
Scar – Discontinued Products 95
Scar – Product Development Milestones 96
Featured News & Press Releases 96
Dec 17, 2014: RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 96
Sep 29, 2014: RXi Pharmaceuticals to Present at the 13th Annual BIO Investor Forum 97
Mar 05, 2014: RXi Pharmaceuticals Granted Key Patent Related to Self-Delivering Technology for the Treatment of Fibrotic Disorders 97
Feb 03, 2014: RXi Pharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference 98
Dec 04, 2013: RXi Pharmaceuticals Announces mRNA Data of an Additional Cohort in the Second Phase 1 Multi-Dose Study with RXI-109, Extending the Dose Response Following Treatment in the Initial 2-week Period 98
Nov 18, 2013: RXi Pharmaceuticals and Ethicor Announce the Signing of a Distribution Agreement for RXI-109 in the European Union under the “Specials” Provision 99
Jul 15, 2013: FirstString Research, Inc. Announces the Achievement of Primary Endpoints in Three Phase 2 Clinical Trials of Granexin™ Gel for the Treatment of Chronic Wounds and Scar Reduction 99
Jul 12, 2013: RXi Pharmaceuticals Announces Positive Data in Second Phase 1 Multi-Dose Study 100
Jun 27, 2013: Pergamum Reports Positive Follow-up Data From Phase II Clinical Trial Of PXL-01 For Prevention Of Post-surgical Adhesions 101
Jun 06, 2013: RXi Pharmaceuticals Announces Positive Results In First Double Blind Study In Healthy Volunteers With RXI-109 101
Appendix 103
Methodology 103
Coverage 103
Secondary Research 103
Primary Research 103
Expert Panel Validation 103
Contact Us 103
Disclaimer 104


【レポート販売概要】

■ タイトル:瘢痕(Scar):治療薬開発パイプライン動向(2015年上半期版)
■ 英文:Scar - Pipeline Review, H1 2015
■ 発行日:2015年3月11日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6266IDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。